During the past decade, Centre Frederic Joliot conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Frederic Joliot" #1 sponsor was "ARCAGY/ GINECO GROUP" with 2 trials, followed by "Intergroupe Francophone de Cancerologie Thoracique" with 2 trials sponsored, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 1 trials sponsored, "Gustave Roussy, Cancer Campus, Grand Paris" with 1 trials sponsored and "Institut Cancerologie de l'Ouest" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Frederic Joliot" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "National Cancer Institute, France" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Centre Frederic Joliot" are "Lung Cancer" (2 trials), "ALK Gene Mutation" (1 trials), "BRAF Gene Mutation" (1 trials), "Breast Cancer" (1 trials) and "Breast Conserving Surgery" (1 trials). Many other conditions were trialed in "Centre Frederic Joliot" in a lesser frequency.

Most popular intervention types in "Centre Frederic Joliot" are "Drug" (4 trials), "Radiation" (4 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Radiotherapy" (2 trials), "radiation therapy" (2 trials), "BKM120" (1 trials), "Blood sampling" (1 trials) and "Chemotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Frederic Joliot" are 6 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Frederic Joliot". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Centre Frederic Joliot, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Frederic Joliot, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".